<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Wet on Tenu Tech Brief</title>
    <link>https://cluster-site.onrender.com/tags/wet/</link>
    <description>Recent content in Wet on Tenu Tech Brief</description>
    <generator>Hugo -- 0.146.0</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 24 Feb 2026 06:03:58 +0000</lastBuildDate>
    <atom:link href="https://cluster-site.onrender.com/tags/wet/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>NASA to Provide Coverage of Artemis II Wet Dress Rehearsal</title>
      <link>https://cluster-site.onrender.com/posts/nasa-to-provide-coverage-of-artemis-ii-wet-dress-rehearsal/</link>
      <pubDate>Wed, 18 Feb 2026 18:07:29 +0000</pubDate>
      <guid>https://cluster-site.onrender.com/posts/nasa-to-provide-coverage-of-artemis-ii-wet-dress-rehearsal/</guid>
      <description>• 2 min read NASA to Provide Coverage of Artemis II Wet Dress Rehearsal Elizabeth Shaw NASA Headquarters As NASA continues preparations for the Artemis II test flight, the agency w</description>
    </item>
    <item>
      <title>Ocular Therapeutix Eyes FDA Filing After Wet AMD Drug Tops Regeneron&#39;s Eylea in Phase 3 Test</title>
      <link>https://cluster-site.onrender.com/posts/ocular-therapeutix-eyes-fda-filing-after-wet-amd-drug-tops-regenerons-eylea-in-phase-3-test/</link>
      <pubDate>Tue, 17 Feb 2026 20:09:28 +0000</pubDate>
      <guid>https://cluster-site.onrender.com/posts/ocular-therapeutix-eyes-fda-filing-after-wet-amd-drug-tops-regenerons-eylea-in-phase-3-test/</guid>
      <description>• In the first of two Phase 3 tests, Ocular Therapeutix&amp;rsquo;s Axpaxli met the main goal of helping maintain vision in patients with the wet form of age-related macular degeneration. •</description>
    </item>
  </channel>
</rss>
